Drugs / Systane® Gel Drops
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02455050 | Dec 2014 → Aug 2015 | dry eye syndrome | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systane Gel Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02455050 ↗ |
| Route | Topical | “1 to 2 drops of Systane® Gel Drops in each eye.” NCT02455050 ↗ |